These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27364757)

  • 1. Toll-like receptors in the pathogenesis of pulmonary fibrosis.
    Karampitsakos T; Woolard T; Bouros D; Tzouvelekis A
    Eur J Pharmacol; 2017 Aug; 808():35-43. PubMed ID: 27364757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis.
    O'Dwyer DN; Armstrong ME; Kooblall M; Donnelly SC
    Expert Opin Ther Targets; 2015 Apr; 19(4):507-14. PubMed ID: 25530171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaching the degradome in idiopathic pulmonary fibrosis.
    Pardo A; Selman M; Kaminski N
    Int J Biochem Cell Biol; 2008; 40(6-7):1141-55. PubMed ID: 18207447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of wound healing and organ fibrosis by toll-like receptors.
    Huebener P; Schwabe RF
    Biochim Biophys Acta; 2013 Jul; 1832(7):1005-17. PubMed ID: 23220258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.
    White ES; Lazar MH; Thannickal VJ
    J Pathol; 2003 Nov; 201(3):343-54. PubMed ID: 14595745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
    Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH
    Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors and autophagy in interstitial lung diseases.
    Margaritopoulos GA; Lasithiotaki I; Antoniou KM
    Eur J Pharmacol; 2017 Aug; 808():28-34. PubMed ID: 27687957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
    Xu X; Dai H; Wang C
    Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review.
    Kinoshita T; Goto T
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.
    Tomos IP; Tzouvelekis A; Aidinis V; Manali ED; Bouros E; Bouros D; Papiris SA
    Expert Rev Respir Med; 2017 Apr; 11(4):299-309. PubMed ID: 28274188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic pulmonary fibrosis].
    Doubková M; Skhicková J
    Vnitr Lek; 2005 Dec; 51(12):1375-84. PubMed ID: 16430105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The innate immune system, toll-like receptors and dermal wound healing: A review.
    Portou MJ; Baker D; Abraham D; Tsui J
    Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids in pulmonary fibrosis.
    Huang LS; Natarajan V
    Adv Biol Regul; 2015 Jan; 57():55-63. PubMed ID: 25446881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
    Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
    Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/Akt signaling is involved in the pathogenesis of bleomycin‑induced pulmonary fibrosis via regulation of epithelial‑mesenchymal transition.
    Zhang XL; Xing RG; Chen L; Liu CR; Miao ZG
    Mol Med Rep; 2016 Dec; 14(6):5699-5706. PubMed ID: 27878273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.
    Selman M; King TE; Pardo A; ; ;
    Ann Intern Med; 2001 Jan; 134(2):136-51. PubMed ID: 11177318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.
    Selman M; Thannickal VJ; Pardo A; Zisman DA; Martinez FJ; Lynch JP
    Drugs; 2004; 64(4):405-30. PubMed ID: 14969575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular matrix and mechanotransduction in pulmonary fibrosis.
    Deng Z; Fear MW; Suk Choi Y; Wood FM; Allahham A; Mutsaers SE; Prêle CM
    Int J Biochem Cell Biol; 2020 Sep; 126():105802. PubMed ID: 32668329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.